Indivior Pharmaceuticals, Inc. INDV Business Segments — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's business segments — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's business segments — operating expenses?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — operating expenses of $139M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's business segments — operating expenses changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's business segments — operating expenses decreased by 10.9% year-over-year, from $156M to $139M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's business segments — operating expenses?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's business segments — operating expenses has grown at a -4.1% compound annual growth rate (CAGR), from $831M to $732M.
- What does business segments — operating expenses mean?
- The aggregate of all operating costs, including selling, general, administrative, and research expenses incurred by the segment. This metric provides a comprehensive view of the operational burden required to sustain the segment's business activities.